Changes in the oral absorption characteristics in man of dipotassium clorazepate at normal and elevated gastric pH.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000378:metabolism*; D003009:Clorazepate Dipotassium / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption; D008297:Male; D008875:Middle Aged; D013270:Stomach / Q000032:analysis
D014151:Anti-Anxiety Agents; D003009:Clorazepate Dipotassium